SHOP: Blocking Peptides,EGF Receptor erbB

Blocking Peptide phospho-EGFR, pTyr 845

Order No. Size sufficient for Price
2003-100/EGFR-pTyr845   189,00  €
 Add Product add to basket
Order No.: 2003-100/EGFR-pTyr845
Description:
Size sufficient for:  
Applications: Blocking of mab EGFR-12A3 (pTyr 845)
Price: 189  €
References: Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer. Hudelist G, Köstler J, Czerwenka K, Kubista E, Attems J, Müller R, Gschwantler-Kaulich D, Manavi M, Huber I, Hoschützky H, Zielinski CC, Singer CF. Int. J. Cancer: 118, 1126-1134 (2006)

Related Products:
  Order No. Cell lysate from Tissue Type
2004-100/EGFR-pTyr1045
2005-100/EGFR-pTyr1068
2007-100/EGFR-pTyr1148
2006-100/EGFR-pTyr1173
2008-100/erbB2-pTyr1248
2009-100/erbB2-pTyr877
2010-100/erbB2-pTyr1139
2011-100/erbB4-pTyr1188
2001-100/VASP-pSer157 2001-100/VASP-pSer157 2001 blocking peptide contol phosphopeptide VASP pSer157 phosphoserine 157
2002-100/VASP-pSer239